Experienced in WT1-Related Wilms Tumor Syndromes

Dr. William K. Oh

Oncology
Yale New Haven Health System
Yale University
35 Park St, 
New Haven, CT 
Offers Telehealth

Experienced in WT1-Related Wilms Tumor Syndromes
Yale New Haven Health System
Yale University
35 Park St, 
New Haven, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Oh is an Oncologist in New Haven, Connecticut. Dr. Oh is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Hemorrhoidectomy.

His clinical research consists of co-authoring 244 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Internal Medicine in NY
Hospital Affiliations
Yale-New Haven Hospital
Greenwich Hospital Association -
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

YALE UNIVERSITY
35 Park St, New Haven, CT 06519
Call: 203-785-4191

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Pilot Study of the Combination of 5-azacitidine (5-AZA) and All-trans Retinoic Acid (ATRA) for Prostate Cancer (PCa) With PSA-only Recurrence After Definitive Local Treatment
A Pilot Study of the Combination of 5-azacitidine (5-AZA) and All-trans Retinoic Acid (ATRA) for Prostate Cancer (PCa) With PSA-only Recurrence After Definitive Local Treatment
Enrollment Status: Completed
Publish Date: April 30, 2024
Intervention Type: Drug
Study Drugs: 5-Azacitidine, All trans retinoic acid, Lupron
Study Phase: Phase 2
Clinical Trial of a Rapidly Cycling, Non-Cross Reactive Regimen of Approved Therapeutic Agents to Treat Prostate Cancer
Clinical Trial of a Rapidly Cycling, Non-Cross Reactive Regimen of Approved Therapeutic Agents to Treat Prostate Cancer
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Drug
Study Drugs: Abiraterone acetate, Prednisone, Radium-223 dichloride, Cabazitaxel, Carboplatin, Enzalutamide
Study Phase: Phase 2
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Enrollment Status: Unknown
Publish Date: September 13, 2023
A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
Enrollment Status: Completed
Publish Date: April 06, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 3 Less Clinical Trials

244 Total Publications

The Effect of Conjugated Bilirubin on the Measurement of Unbound Bilirubin.
The Effect of Conjugated Bilirubin on the Measurement of Unbound Bilirubin.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: August 26, 2025
View All 244 Publications
Similar Doctors
Louis R. Kavoussi
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Louis R. Kavoussi
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Louis R. Kavoussi
Oncology

Northwell Health Physician Partners Smith Institute For Urology At Lake Success

450 Lakeville Road, Suite M42, 
Lake Success, NY 
 (55.0 miles away)
516-734-8500
Languages Spoken:
English
See accepted insurances

Louis Kavoussi is an Oncologist in Lake Success, New York. Dr. Kavoussi is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael E. Hurwitz
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael E. Hurwitz
Oncology

Yale University

20 York St, 
New Haven, CT 
 (0.1 miles away)
203-785-4638
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Hurwitz is an Oncologist in New Haven, Connecticut. Dr. Hurwitz is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Adult Soft Tissue Sarcoma, and Orchiectomy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Chung-han H. Lee
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Chung-han H. Lee
Oncology
500 Westchester Ave, 
West Harrison, NY 
 (45.7 miles away)
646-422-4545
Languages Spoken:
English
See accepted insurances

Chung-han Lee is an Oncologist in West Harrison, New York. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and Familial Wilms Tumor 2.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Oh's expertise for a condition
ConditionClose
  • Elite
  • Prostate Cancer
    Dr. Oh is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Distinguished
  • Familial Prostate Cancer
    Dr. Oh is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Lacrimal Gland Tumor
    Dr. Oh is
    Distinguished
    . Learn about Lacrimal Gland Tumor.
    See more Lacrimal Gland Tumor experts
  • Renal Cell Carcinoma (RCC)
    Dr. Oh is
    Distinguished
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Advanced
  • Bladder Cancer
    Dr. Oh is
    Advanced
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Familial Wilms Tumor 2
    Dr. Oh is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Melanoma of the Eye
    Dr. Oh is
    Advanced
    . Learn about Melanoma of the Eye.
    See more Melanoma of the Eye experts
  • Orchiectomy
    Dr. Oh is
    Advanced
    . Learn about Orchiectomy.
    See more Orchiectomy experts
  • Urothelial Cancer
    Dr. Oh is
    Advanced
    . Learn about Urothelial Cancer.
    See more Urothelial Cancer experts
  • Experienced
  • Adrenal Cancer
    Dr. Oh is
    Experienced
    . Learn about Adrenal Cancer.
    See more Adrenal Cancer experts
  • Agranulocytosis
    Dr. Oh is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Bone Tumor
    Dr. Oh is
    Experienced
    . Learn about Bone Tumor.
    See more Bone Tumor experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Oh is
    Experienced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Oh is
    Experienced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • DICER1 Syndrome
    Dr. Oh is
    Experienced
    . Learn about DICER1 Syndrome.
    See more DICER1 Syndrome experts
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved